Tc Biopharm Plc Stock Gross Profit
TCBPW Stock | USD 0.02 0 24.67% |
TC BioPharm plc fundamentals help investors to digest information that contributes to TC BioPharm's financial success or failures. It also enables traders to predict the movement of TCBPW Stock. The fundamental analysis module provides a way to measure TC BioPharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TC BioPharm stock.
Last Reported | Projected for Next Year | ||
Gross Profit | 4.4 M | 3.1 M |
TCBPW | Gross Profit |
TC BioPharm plc Company Gross Profit Analysis
TC BioPharm's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current TC BioPharm Gross Profit | 3.1M |
Most of TC BioPharm's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TC BioPharm plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
TCBPW Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for TC BioPharm is extremely important. It helps to project a fair market value of TCBPW Stock properly, considering its historical fundamentals such as Gross Profit. Since TC BioPharm's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TC BioPharm's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TC BioPharm's interrelated accounts and indicators.
Click cells to compare fundamentals
TCBPW Gross Profit Historical Pattern
Today, most investors in TC BioPharm Stock are looking for potential investment opportunities by analyzing not only static indicators but also various TC BioPharm's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's gross profit growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of TC BioPharm gross profit as a starting point in their analysis.
TC BioPharm Gross Profit |
Timeline |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
All Next | Launch Module |
TCBPW Fundamentals
Return On Equity | -12.17 | ||||
Return On Asset | -1.09 | ||||
Number Of Shares Shorted | 529 | ||||
EBITDA | (13.61 M) | ||||
Net Income | (5.91 M) | ||||
Cash And Equivalents | 1.55 M | ||||
Cash Per Share | 0.08 X | ||||
Total Debt | 1.8 M | ||||
Current Ratio | 0.18 X | ||||
Book Value Per Share | 3.38 X | ||||
Cash Flow From Operations | (10.54 M) | ||||
Earnings Per Share | (0.75) X | ||||
Number Of Employees | 41 | ||||
Beta | 0.25 | ||||
Total Asset | 8.93 M | ||||
Retained Earnings | (38.84 M) | ||||
Working Capital | 950.33 K | ||||
Net Asset | 8.93 M |
About TC BioPharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TC BioPharm plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TC BioPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TC BioPharm plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TCBPW Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.